Search Videos and More

Showing 1 - 9 of 9 results


Gordon J. Freeman, PhD, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology News

Gordon J. Freeman, PhD, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology

Gordon J. Freeman, PhD, of Dana-Farber Cancer Institute, will receive the 2024 AACR-Cancer Research Institute (CRI) Lloyd J. Old Award in Cancer Immunology from the American Association for Cancer Research (AACR).
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nations’ Best for 2023-2024 News

U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nations’ Best for 2023-2024

For the 23rd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report.
Dana-Farber/Boston Children's Again Ranked Among the Best Pediatric Cancer Programs in the Nation News

Dana-Farber/Boston Children's Again Ranked Among the Best Pediatric Cancer Programs in the Nation

U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the #2 pediatric program in the nation in its 2023-24 Best Children's Hospitals report.
More Than 120 Dana-Farber Affiliated Faculty Named as 2023 Top Doctors in Boston Magazine News

More Than 120 Dana-Farber Affiliated Faculty Named as 2023 Top Doctors in Boston Magazine

Boston magazine has named more than 120 physicians affiliated with Dana-Farber Cancer Institute to its annual "Top Doctors" guide.
Dana-Farber’s Kornelia Polyak Elected to the National Academy of Medicine News

Dana-Farber’s Kornelia Polyak Elected to the National Academy of Medicine

Kornelia Polyak, M.D., Ph.D., professor of medicine, medical oncology, Dana-Farber Cancer Institute has been elected to the prestigious National Academy of Medicine.
Kornelia Polyak Wins Prestigious American Cancer Society Award News

Kornelia Polyak Wins Prestigious American Cancer Society Award

Kornelia Polyak, MD, PhD, a breast cancer researcher at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School is the recipient of the American Cancer Society’s prestigious Research Professor Award.
U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation's Best For 2022-2023 News

U.S. News & World Report Names Dana-Farber Brigham Cancer Center Among Nation's Best For 2022-2023

For the 22nd consecutive year, Dana-Farber Brigham Cancer Center has been recognized as a Best Hospital for cancer care by U.S. News & World Report. This year, Dana-Farber Brigham Cancer Center is ranked as the best hospital for cancer care in New England and #4 in the nation.
Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program News

Dana-Farber/Boston Children's Again Named Top Pediatric Cancer Program

U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center #1 in the nation in its 2022-23 Best Children's Hospitals report. Dana-Farber/Boston Children's has been recognized as one of the top three pediatric cancer centers in the country each year since the ranking's inception, earning more #1 rankings than any other program.
Newsweek Names Dana-Farber #3 in the World for Cancer News

Newsweek Names Dana-Farber #3 in the World for Cancer

Dana-Farber Cancer Institute has been named one of the world’s very best cancer hospitals by Newsweek in its new World’s Best Specialized Hospitals 2022 rankings.